4 Programs

Bharat Biotech’s intranasal Covid vaccine gets nod for phase II trials – Times of India

admin
  1. Bharat Biotech’s intranasal Covid vaccine gets nod for phase II trials  Times of India
  2. Bharat Biotech gets DCGI nod to conduct phase II/III trial of its nasal Covid vaccine  Mint
  3. First nasal vaccine developed by Bharat Biotech gets nod for Phase 2/3 trial  Hindustan Times
  4. Bharat Biotech’s intranasal vaccine gets the nod for phase 2/3 trial  The Hindu
  5. IIL starts Covaxin drug substance supply to Bharat Bio for 3-4 million doses per month  Times of India
  6. View Full coverage on Google News